Skip to main content
letter
. 2019 Sep 12;20:209. doi: 10.1186/s12931-019-1150-7

Table 1.

Logistic regression analysis with adherence (> 4 h /day, 70% of the days) as the dependent variable

Whole population Non adherent
N = 100
Adherent
N = 550
Crude OR [95% CI] p-value Adjusted OR [95% CI] p-value
Demographics
 Age (yrs) 68 [61; 74] 68 [60; 75] 68 [61; 74] 1.00 [0.98; 1.02] 0.80
 Gender, female (%) 173/650 (26.6) 32/100 (32.0) 141/550 (25.6) 0.73 [0.46; 1.16] 0.19
 BMI (kg/m2) 30.8 [27.7; 34.5] 29.4 [26.5; 32.3] 31.1 [27.8; 34.9] 1.07 [1.02; 1.12] 0.003 1.07 [1.01; 1.13] 0.03
 Initial AHI (event/h) 39 [31; 55] 37.9 [30.0; 52.0] 39.0 [31.0; 57.0] 1.01 [0.99; 1.02] 0.16
 Active smokers (%) 77/637 (12.1] 13/99 (13.1) 64/538 (11.9) 0.89 [0.47; 1.69] 0.73
 Beard (%) 75/456 (16.5) 10/64 (15.6) 65/392 (16.6) 1.05 [0.50; 2.18] 0.70
 Mustache (%) 42/456 (9.2) 7/64 (10.9) 35/392 (8.9) 0.81 [0.34; 1.92] 0.60
 No mustache no beard (%) 339/456 (74.3) 47/64 (73.4) 292/392 (74.5) Ref 0.88
 Presence of partner 457/640 (71.4) 61/96 (63.5) 396/544 (72.8) 1.54 [0.97; 2.42] 0.07 2.03 [1.18; 3.50] 0.011
 Active workers 130/632 (20.6) 20/95 (21.1) 110/537 (20.5) 0.97 [0.57; 1.65] 0.90
 ESS (VAS score) 5 [3; 8] 6 [3; 8] 5 [3; 9] 0.99 [0.95; 1.05] 0.87
EQ-5D-3 L
 Problems with mobility (%) 157/623 (25.2) 25/94 (26.6) 132/529 (26.6) 0.92 [0.58; 1.51] 0.74
 Problems with self-care (%) 38/617 (6.2) 6/94 (6.38) 32/523 (6.12) 0.96 [0.39; 2.35] 0.92
 Problems with usual activities (%) 124/620 (20.0) 20/96 (20.8) 104/524 (19.9) 0.94 [0.55; 1.61] 0.82
 Problems of pain/discomfort (%) 347/623 (55.7) 54/96 (56.3) 293/527 (55.6) 0.97 [0.63; 1.51] 0.91
 Problems of anxiety/depression (%) 240/624 (38.5) 41/96 (42.7) 199/528 (37.9) 0.81 [0.52; 1.26] 0.35
 EQ-5D-3 L Health (VAS score) 69.8 [50.2; 80.1] 69.2 [49.4; 80.0] 69.9 [50.4; 80.2] 1.01 [0.99; 1.02] 0.17
Device
 Treatment duration (yrs) 4.9 [2.1; 9.8] 3.8 [1.3; 8.1] 5.1 [2.3; 10.2] 1.06 [1.01; 1.11] 0.02
 Fixed pressure (%) 91/650 (14.0) 12/100 (12.0) 79/550 (14.4) 1.23 [0.64; 2.35] 0.53
 90th/95th Pressure (cmH2O) 10.0 [8.30; 11.8] 9.9 [8.0; 11.5] 10.0 [8.3; 11.8] 1.10 [0.99; 1.21] 0.09
 Oronasal (%) 216/650 (33.2) 43/100 (43.0) 173/550 (31.5) 0.58 [0.37; 0.91] 0.14
 Nasal (%) 375/650 (57.7) 47/100 (47.0) 328/550 (59.6) Ref 0.07
 Nasal pillows (%) 59/650 (9.1) 10/100 (10.0) 49/550 (8.91) 0.70 [0.33; 1.48] 0.83
 Heated humidifier 386/650 (59.4) 66/100 (66.0) 320/550 (58.2) 0.72 [0.46; 1.12] 0.14
 Heated breathing tube 22/650 (3.4) 3/100 (3.0) 19/550 (3.5) 1.16 [0.34; 3.99] 0.82
2013 ATS statement tested thresholds
 Current AHIflow (> 10) 23/650 (3.4) 5/100 (5.0) 17/550 (3.1) 0.61 [0.22; 1.68] 0.34
 ResMed Nasal large leaks (95th > 24 L) 53/154 (34.4) 10/22 (45.5) 43/132 (32.6) 0.58 [0.23; 1.45] 0.24
 ResMed Facial large leaks (95th > 36 L) 28/131 (21.4) 8/23 (34.8) 20/108 (18.5) 0.43 [0.16; 1.14] 0.09
 Philips leaks (> 1 h of large leaks) 11/356 (3.1) 1/55 (1.82) 10/301 (3.32) 1.86 [0.23; 14.8] 0.56
 Fisher Paykel leaks (>  60 L/min) 8/8 (100) 0/8 (0) 8/8 (100) NA
VAS scores
 Patient perceived leaks (VAS score) 3 [1; 5] 3.0 [1.0; 6.0] 3.0 [0.0; 5.0] 0.97 [0.91; 1.05] 0.48
 Patient perceived mouth dryness (VAS score) 3 [0; 7] 5 [1; 8] 3 [0; 7] 0.93 [0.88; 0.99] 0.019